Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Abstract Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome...

Full description

Bibliographic Details
Main Authors: Chiara Citterio, Antonio Lazzaro, Costanza Bosi, Maurice De Ponzio, Luigi Cavanna
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.4013
Description
Summary:Abstract Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.
ISSN:2050-0904